<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00178711</url>
  </required_header>
  <id_info>
    <org_study_id>5U01NS043353-06</org_study_id>
    <secondary_id>FDA-2014-109</secondary_id>
    <nct_id>NCT00178711</nct_id>
  </id_info>
  <brief_title>Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury</brief_title>
  <acronym>NABIS:HIIR</acronym>
  <official_title>National Acute Brain Injury Study: Hypothermia IIR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Induction of hypothermia to &lt; 35˚C by &lt; 2.5 hours after severe traumatic brain injury,
      reaching 33˚C by 4 hours after injury and maintained for 48 hours in patients aged 16-45 will
      result in an increased number of patients with good outcomes at six months after injury
      compared to patients randomized to normothermia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NABIS:HIIR was a randomized clinical trial conducted in patients with severe brain injury,
      age 16-45. Patients were randomized to standard treatment at normothermia or to standard
      treatment with moderate hypothermia (32.5-34C for 48 hours). An intent to treat analysis was
      used with the primary outcome measure as the Glasgow Outcome Scale at six months after
      injury. GOS is dichotomized into good outcome (Good Recovery/Moderate Disability) and poor
      outcome (Severe Disability, Vegetative, Dead).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Futility
  </why_stopped>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Dichotomized Glasgow Outcome Scale</measure>
    <time_frame>6 months with a window of plus or minus one month</time_frame>
    <description>The primary outcome measure was the Glasgow Outcome Scale measured in person six months after injury by examiners who were blinded to the patient's treatment group. Good recovery and moderate disability were designated as favorable outcomes; severe disability, a vegetative state, and death as poor outcomes.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Glasgow Outcome Scale - Extended</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Disability Rating Scale</measure>
    <time_frame>assessed 0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Neurobehavioral Rating Scale - Revised</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Neurological Outcome Scale for Traumatic Brain Injury</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Symbol Digit Modalities Test</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rey Osterrieth Complex Figure</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Verbal Selective Reminding Test Trails B</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Grooved Pegboard</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Controlled Oral Word Association Test</measure>
    <time_frame>0-12 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">232</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>hypothermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Induction and maintenance of moderate hypothermia to 33 degrees celsius achieved within 2.5 hours of injury and maintained for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>treated at normothermia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hypothermia</intervention_name>
    <description>Induction of moderate hypothermia to 33 degrees celsius, within 2.5 hours from time of injury and maintained for 48 hours</description>
    <arm_group_label>hypothermia</arm_group_label>
    <other_name>moderate hypothermia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Non-penetrating brain injury with post-resuscitation Glasgow Coma Score (GCS) &lt; 8
             (motor 1-5)

          2. Estimated or known age &gt; 16 and &lt; 45 years old

          3. Time of Injury within 2.5hrs of arrival at hospital

        Exclusion Criteria:

          1. GCS = 7 or 8 with a normal head Cat Scan (CT) scan or showing only mild Subarachnoid
             hemorrhage (SAH)or skull fracture or GCS &gt; 9 post- randomization

          2. GCS = 3 AND bilaterally non-reactive pupils

          3. Abbreviated Injury Score (AIS) &gt; 4 for any body area except head

          4. Positive abdominal ultrasound or CT scan

          5. Persistent hypotension (systolic blood pressure &lt; 110mmHGg)

          6. Persistent hypoxia (O2 Saturation &lt; 94%)

          7. Positive pregnancy test

          8. Injured greater than 2.5 hours from hospital arrival

          9. Pre-existing medical conditions, if known
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy L Clifton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UTHSC-H</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of St Louis : St. Louis University Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh : University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center, Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charleston Area Medical Center</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Calgary Health Science Center : Foothills Medical Center</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N4N1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Clifton GL, Coffey CS, Fourwinds S, Zygun D, Valadka A, Smith KR Jr, Frisby ML, Bucholz RD, Wilde EA, Levin HS, Okonkwo DO. Early induction of hypothermia for evacuated intracranial hematomas: a post hoc analysis of two clinical trials. J Neurosurg. 2012 Oct;117(4):714-20. doi: 10.3171/2012.6.JNS111690. Epub 2012 Jul 27.</citation>
    <PMID>22839656</PMID>
  </results_reference>
  <results_reference>
    <citation>Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, Janis LS, Wilde E, Taylor P, Harshman K, Conley A, Puccio A, Levin HS, McCauley SR, Bucholz RD, Smith KR, Schmidt JH, Scott JN, Yonas H, Okonkwo DO. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011 Feb;10(2):131-9. doi: 10.1016/S1474-4422(10)70300-8. Epub 2010 Dec 17.</citation>
    <PMID>21169065</PMID>
  </results_reference>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <results_first_submitted>July 31, 2014</results_first_submitted>
  <results_first_submitted_qc>August 8, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 11, 2014</results_first_posted>
  <last_update_submitted>September 13, 2014</last_update_submitted>
  <last_update_submitted_qc>September 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Guy Clifton</investigator_full_name>
    <investigator_title>Professor - Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Traumatic Brain Injury</keyword>
  <keyword>Hypothermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were enrolled in hospitals of University of Texas Health Science Center at Houston, University of Calgary, University of Pittsburgh, St. Louis University, Charleston Area Medical Center, and University of New Mexico.Enrollment occurred from December 2005 to June 2009 with follow-up from June 2006 through December 2009</recruitment_details>
      <pre_assignment_details>Enrollment criteria at the first eligibility assessment were ages 16–45, non-penetrating brain injury, and not responsive to instructions. 232 participants met these criteria and also had none of a first set of exclusion criteria. At the second eligibility assessment, 97 patients had none of a second set of exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Hypothermia</title>
          <description>There were two sets of exclusion criteria-one in the field; the other after resuscitation in the ER. In the field, patients were excluded for suspected pregnancy, systolic blood pressure &lt;110 mm Hg, diastolic blood pressure &lt;60 mm Hg, sustained heart rate &gt;120 beats per minute, or failure to be reached by study-affiliated personnel within 2.5 hours of injury.
Those that did not have any of the first set of exclusion criteria were further assessed for the presence of Glasgow Coma Scale 3-8 without life-threatening associated injuries. The second set of exclusion criteria were GCS 3 with nonreactive pupils, GCS 7-8 with normal brain CT scan, inability to obtain an accurate GCS, Abbreviated Injury Severity Score &gt;4 for organs other than brain4, systolic blood pressure &lt;110 mm Hg or diastolic blood pressure &lt;60 mm Hg, persistent hypoxia, (oxygen saturation &lt; 94%), or positive pregnancy test.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>45 patients who had none of the second set of exclusion criteria and who has been randomized to normothermia served as the control group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>hypothermia group-- 26 ± 9 years of age, 40 males/12 females normothermia group--31 ± 11 year of age, 41 males/4 females</population>
      <group_list>
        <group group_id="B1">
          <title>Hypothermia</title>
          <description>Induction and maintenance of moderate hypothermia to 33 degrees celsius achieved within 4 hours of injury and maintained for 48 hours.
Hypothermia: Induction of moderate hypothermia to 33 degrees celsius, within 4 hours from time of injury and maintained for 48 hours</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Treated at normothermia</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="45"/>
            <count group_id="B3" value="97"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26" spread="9"/>
                    <measurement group_id="B2" value="31" spread="11"/>
                    <measurement group_id="B3" value="28" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Dichotomized Glasgow Outcome Scale</title>
        <description>The primary outcome measure was the Glasgow Outcome Scale measured in person six months after injury by examiners who were blinded to the patient's treatment group. Good recovery and moderate disability were designated as favorable outcomes; severe disability, a vegetative state, and death as poor outcomes.</description>
        <time_frame>6 months with a window of plus or minus one month</time_frame>
        <population>Intention to Treat</population>
        <group_list>
          <group group_id="O1">
            <title>Hypothermia</title>
            <description>Induction and maintenance of moderate hypothermia to 33 degrees celsius achieved within 4 hours of injury and maintained for 48 hours.
Hypothermia: Induction of moderate hypothermia to 33 degrees celsius, within 4 hours from time of injury and maintained for 48 hours</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>treated at normothermia</description>
          </group>
        </group_list>
        <measure>
          <title>The Dichotomized Glasgow Outcome Scale</title>
          <description>The primary outcome measure was the Glasgow Outcome Scale measured in person six months after injury by examiners who were blinded to the patient's treatment group. Good recovery and moderate disability were designated as favorable outcomes; severe disability, a vegetative state, and death as poor outcomes.</description>
          <population>Intention to Treat</population>
          <units>participants with a poor outcome</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31" lower_limit="0.76" upper_limit="1.53"/>
                    <measurement group_id="O2" value="25" lower_limit="0.76" upper_limit="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The primary hypothesis was a two-sided test assessing whether the induction of hypothermia modified the percentage of subjects with poor outcomes at 6 months after injury. Percentages in each group were compared using a generalized linear model with a binomial distribution and log link function, logistic regression model with admission age and baseline GCS as covariates.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.67</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.76</ci_lower_limit>
            <ci_upper_limit>1.53</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Glasgow Outcome Scale - Extended</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Disability Rating Scale</title>
        <time_frame>assessed 0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neurobehavioral Rating Scale – Revised</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neurological Outcome Scale for Traumatic Brain Injury</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Symbol Digit Modalities Test</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Rey Osterrieth Complex Figure</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Verbal Selective Reminding Test Trails B</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Grooved Pegboard</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Controlled Oral Word Association Test</title>
        <time_frame>0-12 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were reported from the time of the second eligibility assessment to the time of discharge from the acute-care hospital. Generally patients were discharged from the acute care hospital within 3 months of admission.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Randomized to Hypothermia and Hypothermia Maintained</title>
          <description>Induction and maintenance of moderate hypothermia and not excluded by second set of exclusion criteria</description>
        </group>
        <group group_id="E2">
          <title>Randomized to Normothermia and Normothermia Maintained</title>
          <description>Induction and maintenance of normothermia and not excluded by second set of exclusion criteria</description>
        </group>
        <group group_id="E3">
          <title>Randomized to Hypothermia and Then Excluded</title>
          <description>Induction and maintenance of moderate hypothermia before trauma evaluation in ED and then excluded by second set of criteria</description>
        </group>
        <group group_id="E4">
          <title>Randomized to Normothermia Then Excluded</title>
          <description>Maintenance of normothermia before trauma evaluation in ED and then excluded by second set of criteria</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Standard Terminology</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="45"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="67"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>systolic blood pressure &lt; 90 mm Hg or Mean Arterial Pressure &lt; 70 mm Hg for 2 or more consecutive hours associated with end-organ failure due to hypo-perfusion</description>
                <counts group_id="E1" events="6" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <description>sudden or unexpected cessation of pumping action of the heart</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothermia</sub_title>
                <description>rectal or core temperature less than or equal to 32 degrees C for any period of time not induced or related to general anesthesia</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Multiple Organ Dysfunction</sub_title>
                <description>a pattern of simultaneous or near simultaneous organ failure in at least 3 organ systems.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Clinical Sepsis</sub_title>
                <description>At least one of following:
fever &gt; 38 degrees C SBP &lt; 90 mmHg oliguria (&lt; 20 cc/hr) AND blood culture NOT done or NO organisms in blood no apparent infection at another site physician institutes treatment for sepsis</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Blood Stream Infection</sub_title>
                <description>Has a recognized pathogen from 1 or more blood cultures and organism is not related to infection at another site; or has fever &gt;38C or chills or hypotension and positive blood culture</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Catheter Positive Culture</sub_title>
                <description>&gt;15 colonies of pathogenic microorganisms cultured from an arterial or central venous catheter tip associated with clinical sepsis or laboratory-confirmed bloodstream infection</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Elevated Intracranial Pressure</sub_title>
                <description>Intracranial pressure levels greater than 30mmHg for more than 30 minutes or levels greater than 40 mmHg for 5 minutes, non-responsive to maximal medical management and requires initiation of barbiturate coma.</description>
                <counts group_id="E1" events="91" subjects_affected="14" subjects_at_risk="52"/>
                <counts group_id="E2" events="20" subjects_affected="9" subjects_at_risk="45"/>
                <counts group_id="E3" events="7" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Decreased Cerebral Perfusion Pressure</sub_title>
                <description>Cerebral perfusion pressure &lt;50 mmHg for each occurrence documented on the physiology case report form during hourly data collection</description>
                <counts group_id="E1" events="46" subjects_affected="21" subjects_at_risk="52"/>
                <counts group_id="E2" events="34" subjects_affected="13" subjects_at_risk="45"/>
                <counts group_id="E3" events="15" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Subdural Hemorrhage</sub_title>
                <description>New hemorrhage into subdural space requiring surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Intraparenchymal Hemorrhage</sub_title>
                <description>New hemorrhage into brain tissue requiring surgery</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Tentorial Herniation</sub_title>
                <description>acute clinical neurologic deterioration with pupillary dilation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Epidural Hemorrhage</sub_title>
                <description>New hemorrhage into epidural space. (Does not include EDH from initial injury but includes a re-bleed into the previously evacuated surgical site</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <description>acute hypoxia associated with high probability ventilation-perfusion scan, positive Spiral CT scan, computed tomography angiography or MRI associated with hypotension or persistent SaO2 less than 90% for greater than or equal to 2 hours</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Distress Syndrome</sub_title>
                <description>Presence of all 3 of the following;
bilateral pulmonary infiltrates
a PCWP&lt;18 mm Hg
a consistent PO2:FiO2 ratio of &lt;200 for greater than or equal to 3 hours</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="52"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Hypoxemia</sub_title>
                <description>pO2 &lt;50 mm Hg on greater than or equal to 70% FIO2 or persistent O2 saturation &lt;94% for greater than or equal to 2 hours</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Hemothorax</sub_title>
                <description>presence of blood in the pleural cavity which is not present on admission chest x-ray which drains &gt;200 ml/hr for greater than or equal to 2 hours</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <description>Presence of air in the pleural cavity which is not present on admission x-ray associated with hypoxemia or respiratory distress</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>Standard Terminology</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="45"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="67"/>
                <counts group_id="E4" subjects_affected="30" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>hypotension</sub_title>
                <description>Systolic blood pressure &lt;90 mm Hg or Mean arterial pressure &lt;70 mm Hg for 2 or more consecutive hours but not associated with end-organ failure due to hypoperfusion (see Serious Adverse events for definition of critical hypotension)</description>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="52"/>
                <counts group_id="E2" events="7" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E3" events="10" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E4" events="21" subjects_affected="4" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Elevated Intracranial Pressure</sub_title>
                <description>Intracranial pressure &gt; 20 mm Hg for 2 or more consecutive hours but that does not meet the definition of critical elevated intracranial pressure (See serious adverse events for that definition)</description>
                <counts group_id="E1" events="244" subjects_affected="23" subjects_at_risk="52"/>
                <counts group_id="E2" events="128" subjects_affected="18" subjects_at_risk="45"/>
                <counts group_id="E3" events="82" subjects_affected="8" subjects_at_risk="67"/>
                <counts group_id="E4" events="30" subjects_affected="7" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Decreased Cerebral Perfusion Pressure</sub_title>
                <description>Cerebral perfusion pressure &lt;60 mm Hg for 2 or more consecutive hours but that does not meet the definition of critical decreased perfusion pressure (See serious adverse events for that definition)</description>
                <counts group_id="E1" events="36" subjects_affected="3" subjects_at_risk="52"/>
                <counts group_id="E2" events="20" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E3" events="31" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <description>Fever &gt;38C and positive urine culture or physician diagnosis of urinary tract infection</description>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="52"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="45"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <description>new or progressive infiltrated, consolidation or pleural effusion on chest x-ray and at least one of the following:
New onset of purulent sputum
isolation of a etiologic agent
Diagnostic antibody titer or detection of viral antigen</description>
                <counts group_id="E1" events="29" subjects_affected="28" subjects_at_risk="52"/>
                <counts group_id="E2" events="33" subjects_affected="28" subjects_at_risk="45"/>
                <counts group_id="E3" events="20" subjects_affected="17" subjects_at_risk="67"/>
                <counts group_id="E4" events="19" subjects_affected="17" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <description>presence of air in the pleural cavity which is not present on admission x-ray and is not associated with hypoxemia or respiratory distress</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="52"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus</sub_title>
                <description>new ulceration of the skin and subcutaneous tissue which is pressure-related; code only Stage II ulcers or higher (through epidermis and dermis)</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="52"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <description>diagnostic (ultrasound, venogram, Doppler studies) evidence of deep vein thrombosis</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="52"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination for futility.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Guy L Clifton</name_or_title>
      <organization>University of Texas Health Science Center</organization>
      <phone>2024224824</phone>
      <email>guy@guyclifton.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

